APA

Bajetta E., Di Bartolomeo M., Buzzoni R., Mariani L., Zilembo N., Ferrario E., Lo Vullo S., Aitini E., Isa L., Barone C., Jacobelli S., Recaldin E., Pinotti G. & Iop A. (20070321). Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. : British journal of cancer.

Chicago

Bajetta E, Di Bartolomeo M, Buzzoni R, Mariani L, Zilembo N, Ferrario E, Lo Vullo S, Aitini E, Isa L, Barone C, Jacobelli S, Recaldin E, Pinotti G and Iop A. 20070321. Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. : British journal of cancer.

Harvard

Bajetta E., Di Bartolomeo M., Buzzoni R., Mariani L., Zilembo N., Ferrario E., Lo Vullo S., Aitini E., Isa L., Barone C., Jacobelli S., Recaldin E., Pinotti G. and Iop A. (20070321). Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. : British journal of cancer.

MLA

Bajetta E, Di Bartolomeo M, Buzzoni R, Mariani L, Zilembo N, Ferrario E, Lo Vullo S, Aitini E, Isa L, Barone C, Jacobelli S, Recaldin E, Pinotti G and Iop A. Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. : British journal of cancer. 20070321.